PREDICTION OF ADVANCED FIBROSIS USING METABOLIC AND GENETIC FACTORS IN PATIENTS WITH BIOPSY-PROVEN NON-ALCOHOLIC FATTY LIVER DISEASE

被引：0
|
作者：
Kim, DongYun [1 ,2 ]
Lee, Jae Seung [1 ,3 ,4 ]
Lee, Hye Won [1 ,3 ,4 ]
Kim, Beom Kyung [1 ,3 ,4 ]
Kim, Seung Up [1 ,3 ,4 ]
Kim, Do Young, Sr. [1 ,3 ,4 ]
Ahn, Sang Hoon [1 ,3 ,4 ]
Han, Kwang-Hyub [1 ,3 ,4 ]
Park, Jun Yong [1 ,3 ,4 ]
机构：
[1] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Dept Pharmacol, Seoul, South Korea
[3] Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea
[4] Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea
来源：
HEPATOLOGY | 2019年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1733
引用
收藏
页码：1045A / 1045A
页数：1
相关论文
共 50 条
  • [1] EXERCISE BEHAVIOR IN PATIENTS WITH BIOPSY-PROVEN NON-ALCOHOLIC FATTY LIVER DISEASE
    Glass, Oliver
    Wang, Ying
    Liu, Daniel
    Guy, Cynthia D.
    Diehl, Anna Mae
    Abdelmalek, Manal F.
    HEPATOLOGY, 2019, 70 : 748A - 748A
  • [2] Risk factors for biopsy-proven advanced non-alcoholic fatty liver disease in the Veterans Health Administration
    Patel, Y. A.
    Gifford, E. J.
    Glass, L. M.
    McNeil, R.
    Turner, M. J.
    Han, B.
    Provenzale, D.
    Choi, S. S.
    Moylan, C. A.
    Hunt, C. M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (02) : 268 - 278
  • [3] Incidence of Non-Alcoholic Fatty Liver Disease in Patients With Biopsy-Proven Celiac Disease
    Shah, Apeksha
    Wong, She-Yan
    Janowski, Raymond
    Moleski, Stephanie M.
    Halegoua-De Marzio, Dina
    GASTROENTEROLOGY, 2016, 150 (04) : S1145 - S1145
  • [4] The Predictive Role of Extracellular NAPRT for the Detection of Advanced Fibrosis in Biopsy-Proven Non-Alcoholic Fatty Liver Disease
    Armandi, Angelo
    Colombo, Giorgia
    Rosso, Chiara
    Caviglia, Gian Paolo
    Olivero, Antonella
    Abate, Maria Lorena
    Guariglia, Marta
    del Campo, Nuria Perez Diaz
    Castelnuovo, Gabriele
    Ribaldone, Davide Giuseppe
    Saracco, Giorgio Maria
    Genazzani, Armando A.
    Bugianesi, Elisabetta
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (02)
  • [5] Growth differentiation factor 15 predicts advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease
    Koo, Bo Kyung
    Um, Sung Hee
    Seo, Dong Soo
    Joo, Sae Kyung
    Bae, Jeong Mo
    Park, Jeong Hwan
    Chang, Mee Soo
    Kim, Jung Ho
    Lee, Jieun
    Jeong, Won-Il
    Kim, Won
    LIVER INTERNATIONAL, 2018, 38 (04) : 695 - 705
  • [6] Biopsy-proven Non-alcoholic Fatty Liver Disease and Incident Cancer
    Kim, Hee Yeon
    KOREAN JOURNAL OF GASTROENTEROLOGY, 2021, 78 (06): : 362 - 363
  • [7] Validation of non-invasive fibrosis assessments in biopsy-proven non-alcoholic fatty liver disease
    Drolz, A.
    Wehmeyer, M.
    Diedrich, T.
    Wiesch, J. S. zur
    Lohse, A. W.
    Kluwe, J.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S150 - S151
  • [8] Risk factors associated with subclinical atherosclerosis in the patients with biopsy-proven non-alcoholic fatty liver disease
    Arai, Taeang
    Atsukawa, Masanori
    Tsubota, Akihito
    Yoshida, Yuji
    Okubo, Tomomi
    Hayama, Korenobu
    Nakagawa, Ai
    Itokawa, Norio
    Kondo, Chisa
    Iio, Etsuko
    Tanaka, Yasuhito
    Iwakiri, Katsuhiko
    JOURNAL OF HEPATOLOGY, 2020, 73 : S168 - S169
  • [9] The comparison of resting metabolic rate between biopsy-proven non-alcoholic steatohepatitis and non-alcoholic fatty liver patients
    Kenger, Emre Batuhan
    Guveli, Hakan
    Ergun, Can
    Kaya, Eda
    Yilmaz, Yusuf
    HEPATOLOGY FORUM, 2020, 1 (01): : 14 - 19
  • [10] Biopsy Proven Fibrosis in Non-Alcoholic Fatty Liver Disease: An Analysis of Risk Factors
    Pattnaik, Kaumudee
    Bhuyan, Pallavi
    Singh, Ayaskant
    Singh, Shivaram P.
    Nath, Preetam
    Kar, Sanjib
    Misra, Bijay
    Rath, Jayashree
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2018, 8 (04) : 367 - 374
12345